Stock FDMT 4D MOLECULAR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Real-time Estimate Cboe BZX
Other stock markets
 03:23:24 2024-04-19 pm EDT 		5-day change 1st Jan Change
24.95 USD +0.69% Intraday chart for 4D Molecular Therapeutics, Inc. -6.26% +21.92%
Apr. 15 Barclays Starts 4D Molecular Therapeutics With Overweight Rating, $45 Price Target MT
Apr. 15 RBC Raises Price Target on 4D Molecular Therapeutics to $40 From $35, Keeps Outperform Rating, Speculative Risk Qualifier MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. FDMT Stock
  4. News 4D Molecular Therapeutics, Inc.
  5. Official Publications